Halozyme Therapeutics Inc. Common Stock vs Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.45 (market cap $12.58B), while Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) trades at $8.02 (market cap $8.29B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) pays a 4.82% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) for 0 Days on average.
| HALO | UGP | |
|---|---|---|
Market Cap | $12.58B | $8.29B |
Volume | 2,179,278 | 4,931,275 |
Sector | Health | Energy |
52-Week High | $115.22 | $7.79 |
52-Week Low | $61.63 | $3.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $10.34B |
Dividend Yield | — | 4.82% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Ultrapar is a Brazilian company with fuel distribution, liquefied petroleum gas, and chemical businesses. Its consumer-facing operations include fuel and gas distribution brands.
Read more on UGP →